Atlas Trials

Omacetaxine + Azacitidine in Untreated Patients With High Grade MDS

Clinical trial NCT03564873 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03564873
Sponsor
University of Colorado, Denver
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
High Grade Myelodysplastic Syndromes
Start date
2018-09-17
Primary completion
2025-10-07
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.